Jack Nathan Medical Corp.
JNHMF
$0.0036
-$0.0001-2.70%
OTC PK
| 01/31/2025 | 10/31/2024 | 07/31/2024 | 04/30/2024 | 01/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 6.14M | 6.66M | 6.45M | 5.94M | 5.17M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 6.14M | 6.66M | 6.45M | 5.94M | 5.17M |
| Cost of Revenue | 942.50K | 1.17M | 1.34M | 1.40M | 1.17M |
| Gross Profit | 5.20M | 5.49M | 5.12M | 4.54M | 4.00M |
| SG&A Expenses | 6.77M | 8.16M | 7.62M | 6.55M | 5.41M |
| Depreciation & Amortization | 195.40K | 296.00K | 217.40K | 249.20K | 224.60K |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 7.91M | 9.63M | 9.17M | 8.21M | 6.80M |
| Operating Income | -1.77M | -2.97M | -2.72M | -2.27M | -1.63M |
| Income Before Tax | -1.77M | -2.80M | -3.00M | -2.45M | -1.61M |
| Income Tax Expenses | -79.80K | -14.50K | -14.50K | -14.50K | -- |
| Earnings from Continuing Operations | -1.69 | -2.19 | -2.39 | -1.84 | -1.01 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 5.34M | -6.12M | -6.31M | -5.77M | -4.94M |
| EBIT | -1.77M | -2.97M | -2.72M | -2.27M | -1.63M |
| EBITDA | -1.17M | -2.25M | -2.07M | -1.58M | -968.50K |
| EPS Basic | 0.06 | -0.07 | -0.07 | -0.07 | -0.06 |
| Normalized Basic EPS | -0.01 | -0.03 | -0.02 | -0.02 | -0.01 |
| EPS Diluted | 0.06 | -0.07 | -0.07 | -0.07 | -0.06 |
| Normalized Diluted EPS | -0.01 | -0.02 | -0.02 | -0.02 | -0.01 |
| Average Basic Shares Outstanding | 348.40M | 346.83M | 345.22M | 342.85M | 340.07M |
| Average Diluted Shares Outstanding | 366.74M | 364.84M | 358.23M | 359.18M | 347.39M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |